News - Patents

Filter

Current filters:

Patents

Popular Filters

74 to 98 of 432 results

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

Pharmaceutical patent sale of first-in-class compounds to treat women's health needs

31-08-2013

IP Shakti, an early-stage seed fund for biomedical and life science innovations and the exclusive broker…

BezielleIP ShaktiLicensingMenerbaPatentsPharmaceuticalSealaWomen's Health

Imprimis acquires IP rights to ophthalmic compound

30-08-2013

USA-based Imprimis Pharmaceuticals (Nasdaq: IMMY), which is focused on the commercialization of drug…

Imprimis PharmaceuticalsIPI-140OphthalmicsPatentsPharmaceutical

Actavis challenges Rayos patent

28-08-2013

US generic drugmaker Actavis (NYSE: ACT) has confirmed filing an Abbreviated New Drug Application with…

ActavisGenericsHorizon PharmaImmunologicalsInflammatory diseasesPatentsRayos

Aid group urges countries not to trade away health as TPP negotiations intensify

23-08-2013

The far-reaching Trans-Pacific Partnership Agreement (TPP) should be a force for improving health outcomes…

GenericsGlobalPatentsPharmaceuticalPricing

Study highlights the steps to shape effective counter-generics strategies

23-08-2013

More than half of pharmaceutical companies - and 71% of the largest (top 10) companies - maintain a dedicated…

GenericsManagementMarkets & MarketingPatents

Horizon Pharma in Duexis patent settlement

22-08-2013

Horizon Pharma (Nasdaq: HZNP) says it has entered into settlement and license agreements with Par Pharmaceutical…

Anti-Arthritics/RheumaticsDuexisGenericsHorizon PharmaNorth AmericaPar PharmaceuticalPatentsPharmaceutical

Two more drug patents revoked in India

12-08-2013

In another blow for intellectual property in India, local drugmaker Ajanta Pharma has prevailed in revoking…

Ajanta PharmaAllerganAsia-PacificCombiganGanfortGenericsOphthalmicsPatentsPharmaceutical

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

Analyst's view on Irish pharma export woes

29-07-2013

Following the news that Ireland's pharmaceutical industry has experienced a sharp fall in exports due…

EuropeMarkets & MarketingPatentsPharmaceuticalProduction

Mylan enters Tarceva settlement agreement

24-07-2013

US generics firm Mylan (Nasdaq: MYL) has entered into a settlement agreement with OSI Pharmaceuticals,…

GenentechGenericsLegalMylan LaboratoriesNorth AmericaOncologyOSI PharmaceuticalsPatentsPfizerTarceva

Patent settlement curbs could reduce incentives to bring generics to market; report

23-07-2013

A new white paper released this week, titled The Benefits of Patent Settlements: New Survey Evidence…

GenericsNorth AmericaPatentsPharmaceutical

US appeals court reverses paroxetine order in favor of Mylan

23-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) today (July 23) announced that the US Third Circuit Court of…

ApotexGenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalNorth AmericaparoxetinePatentsPaxil

Mylan victorious in patent dispute with Teva

18-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) says that Israel-based Teva Pharmaceuticals Industries (NYSE:…

GenericsMylan LaboratoriesNorth AmericaPatentsPerforomistPharmaceuticalTeva Pharmaceutical Industries

Indian citizens lack free access to essential generic medicines, while policies risk undermining new drug research funding

17-07-2013

Modern India has the third largest national economy in the world in purchasing power adjusted terms.…

Asia-PacificFinancialGenericsHealthcarePatentsResearch

US Court denies re-hearing of Arzerra patent case

16-07-2013

Danish drugmaker Genmab (OMX: GEN) says that the US Court of Appeals for the Federal Circuit has declined…

ArzerraBiogen IdecBiotechnologyGenentechGenmabGlaxoSmithKlineLegalNorth AmericaOncologyPatentsPharmaceutical

Enhanced IP protection for medicines will help Canada with trade agreements, says think-tank

16-07-2013

Canada's protection of intellectual property (IP) in the pharmaceutical industry falls short of international…

Markets & MarketingNorth AmericaPatentsPharmaceutical

Medecins Sans Frontieres wants the Trans-Pacific Partnership to amend terms

16-07-2013

Worldwide humanitarian organization Medecins Sans Frontieres (MSF) is urging the countries participating…

Asia-PacificGenericsPatentsPharmaceuticalPricing

Actavis confirms Vimpat patent challenge and gets OK for generic Opana

15-07-2013

US generics major Actavis (NYSE: ACT) confirmed on Friday (July 12) that it has filed an Abbreviated…

ActavisEndo Health SolutionsGenericsLegalNeurologicalNorth AmericaOpana ERPatentsRegulationUCBVimpat

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

74 to 98 of 432 results

Back to top